Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 33.9 50.5 67.1% View Chart
P/BV x 5.8 15.0 38.8% View Chart
Dividend Yield % 0.6 0.5 128.2%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-19
ABBOTT INDIA
Mar-19
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,8408,834 43.5%   
Low Rs2,0805,458 38.1%   
Sales per share (Unadj.) Rs455.01,731.1 26.3%  
Earnings per share (Unadj.) Rs93.8211.9 44.3%  
Cash flow per share (Unadj.) Rs109.4219.9 49.7%  
Dividends per share (Unadj.) Rs22.5065.00 34.6%  
Dividend yield (eoy) %0.80.9 83.6%  
Book value per share (Unadj.) Rs658.2945.2 69.6%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.1 157.6%   
Avg P/E ratio x31.633.7 93.6%  
P/CF ratio (eoy) x27.132.5 83.3%  
Price / Book Value ratio x4.57.6 59.5%  
Dividend payout %24.030.7 78.2%   
Avg Mkt Cap Rs m135,420151,848 89.2%   
No. of employees `0002.63.5 75.5%   
Total wages/salary Rs m3,2384,356 74.3%   
Avg. sales/employee Rs Th7,911.410,555.5 75.0%   
Avg. wages/employee Rs Th1,230.91,249.9 98.5%   
Avg. net profit/employee Rs Th1,630.71,292.2 126.2%   
INCOME DATA
Net Sales Rs m20,81536,786 56.6%  
Other income Rs m1,6741,133 147.8%   
Total revenues Rs m22,48937,919 59.3%   
Gross profit Rs m5,7126,047 94.5%  
Depreciation Rs m714169 421.9%   
Interest Rs m7323 324.0%   
Profit before tax Rs m6,5996,989 94.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3092,485 92.9%   
Profit after tax Rs m4,2914,503 95.3%  
Gross profit margin %27.416.4 166.9%  
Effective tax rate %35.035.6 98.4%   
Net profit margin %20.612.2 168.4%  
BALANCE SHEET DATA
Current assets Rs m27,16727,610 98.4%   
Current liabilities Rs m8,9178,569 104.1%   
Net working cap to sales %87.751.8 169.4%  
Current ratio x3.03.2 94.6%  
Inventory Days Days6860 112.6%  
Debtors Days Days3027 109.9%  
Net fixed assets Rs m8,8621,057 838.5%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m29,65619,873 149.2%   
Net worth Rs m30,11320,086 149.9%   
Long term debt Rs m250-   
Total assets Rs m39,40029,409 134.0%  
Interest coverage x91.5311.6 29.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 42.2%   
Return on assets %11.115.4 72.0%  
Return on equity %14.222.4 63.5%  
Return on capital %22.134.9 63.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m428369 116.1%   
Fx outflow Rs m7864,918 16.0%   
Net fx Rs m-358-4,549 7.9%   
CASH FLOW
From Operations Rs m9784,991 19.6%  
From Investments Rs m351-2,570 -13.7%  
From Financial Activity Rs m-1,099-1,428 76.9%  
Net Cashflow Rs m231993 23.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  SUVEN LIFESCIENCES  

Compare PFIZER With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Volatile Day for Indian Indices: Sensex Ends 131 Points Lower Post Rebound; Telecom and Auto Stocks Bleed(Closing)

It was a volatile day for India share markets today. The benchmark indices opened higher but turned volatile.

Related Views on News

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

This Crorepati Stock Could Be the Best Vaccine for Your Portfolio Against Coronavirus(Profit Hunter)

Mar 17, 2020

If there is one stock I had to recommend you amid Coronavirus outbreak, this would be it.

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Real Long-Term Impact of the Coronavirus on India(The 5 Minute Wrapup)

Mar 18, 2020

My view on the impact of the Coronavirus on the Indian economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 27, 2020 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS